Evidence map›Paper›PMID 41827779›Full record

ArticleCancers2026

Prognostic Value of the CALLY Index in Diffuse Large B-Cell Lymphoma: Linking Inflammation, Nutrition, and Tumor Biology.

Zorica Cvetković, Ilija Bukurecki, Snežana Pejić, Anica Divac Pravdić, Miroslav Pavlović, Vesna Vučić, Olivera Marković

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Zorica CvetkovićDepartment of Hematology, University Hospital Medical Center Zemun, 11080 Belgrade, Serbia.ORCID 0000-0003-4428-7253
Ilija BukureckiDepartment of Hematology, University Hospital Medical Center Bežanijska Kosa, 11080 Belgrade, Serbia.
Snežana PejićDepartment of Molecular Biology and Endocrinology, Institute of Nuclear Sciences, National Institute of the Republic of Serbia, University of Belgrade, 11000 Belgrade, Serbia.ORCID 0000-0003-4573-2371
Anica Divac PravdićDepartment of Hematology, University Hospital Medical Center Bežanijska Kosa, 11080 Belgrade, Serbia.ORCID 0000-0002-4555-0474
Miroslav PavlovićDepartment of Hematology, University Hospital Medical Center Zvezdara, 11000 Belgrade, Serbia.
Vesna VučićCenter of Research Excellence in Nutrition and Metabolism, Institute for Medical Research, National Institute of the Republic of Serbia, University of Belgrade, 11000 Belgrade, Serbia.ORCID 0000-0002-8563-594X
Olivera MarkovićFaculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.ORCID 0000-0002-5957-0716

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

biomarkerCALLY indexdiffuse large B-cell lymphoma (DLBCL)prognosisrelapsed/refractory (R/R)

Identifiers

PMID41827779
PMCPMC12984221

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.